title: West Nile Virus Central Nervous System Infection in Patients Treated With Rituximab: Implications for Diagnosis and Prognosis, With a Review of Literature.
abstract: The spectrum of West Nile virus (WNV) infection continues to be elucidated. Many cases of WNV are asymptomatic; however, in immunocompromised patients, symptoms are more likely to be severe. We describe fatal WNV central nervous system disease in lymphoma patients who received rituximab, blunting the inflammatory response and complicating diagnosis.
authors.affiliation: Infectious Disease Service, Department of Medicine.
authors.forename: Sejal
authors.initials: S
authors.lastname: Morjaria
authors.affiliation: Infectious Disease Service, Department of Medicine.
authors.forename: Esther
authors.initials: E
authors.lastname: Arguello
authors.affiliation: Infectious Disease Service, Department of Medicine.
authors.forename: Ying
authors.initials: Y
authors.lastname: Taur
authors.affiliation: Infectious Disease Service, Department of Medicine.
authors.forename: Kent
authors.initials: K
authors.lastname: Sepkowitz
authors.affiliation: Neuroradiology Service, Department of Radiology.
authors.forename: Vaios
authors.initials: V
authors.lastname: Hatzoglou
authors.affiliation: Neuroradiology Service, Department of Radiology.
authors.forename: Ajay
authors.initials: A
authors.lastname: Nemade
authors.affiliation: Departments of Pathology.
authors.forename: Marc
authors.initials: M
authors.lastname: Rosenblum
authors.affiliation: Departments of Pathology.
authors.forename: Marcela S
authors.initials: MS
authors.lastname: Cavalcanti
authors.affiliation: Immunology and Medicine , Memorial Sloan-Kettering Cancer Center , New York, New York.
authors.forename: M Lia
authors.initials: ML
authors.lastname: Palomba
authors.affiliation: Infectious Disease Service, Department of Medicine.
authors.forename: Anna
authors.initials: A
authors.lastname: Kaltsas
keywords: West Nile virus; immunocompromised host; lymphoma; molecular testing; rituximab